Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avotaciclib + Capecitabine in Metastatic Colorectal Cancer
NCT05093907Phase 2Recruiting
- Sponsor
- BeyondBio Inc.
- Start
- Aug 2021
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Avotaciclib in metastatic colorectal cancer (mCRC), sponsored by BeyondBio Inc.. Started Aug 2021; status: recruiting.
02
Drugs
Avotaciclib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT05093907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05093907.